Response of a Human T Cell Clone to a Large Panel of Altered Peptide Ligands Carrying Single Residue Substitutions in an Antigenic Peptide: Characterization and Frequencies of TCR Agonism and TCR Antagonism with or Without Partial Activation

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 3783-3790

  Chen, Yu Zhen ^a   Matsushita, Sho ^a   Nishimura, Yasuharu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; HLA DR4 ANTIGEN; LEUKOCYTE ANTIGEN; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT; PEPTIDE LIBRARY;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; BIOSYNTHESIS; CELL SIZE; CHEMISTRY; COMPARATIVE STUDY; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; STRUCTURE ACTIVITY RELATION; TH1 CELL;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; ANTIGENS, CD; CELL SIZE; HLA-DR4 ANTIGEN; HUMANS; INTERFERON TYPE II; LIGANDS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; RECEPTORS, ANTIGEN, T-CELL; STRUCTURE-ACTIVITY RELATIONSHIP; TH1 CELLS;

EID: 0030293628     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403.
2. O'Sullivan, D., J. Sidney, E. Appella, L. Walker, L. Phillips. S. M. Colon, C. Miles, R. W. Chesnut, and A. Sette. 1990. Characterization of peptide binding to four DR haplotypes. J. Immunol. 145:1799.
3. Krieger, J. I., R. W. Karr, H. M. Grey, W. Y. Yu, D. O'Sullivan, L. Batovsky, Z. L. Zheng, S. M. Colon, F. C. A. Gaeta, J. Sidney, M. Albertson, M. F. Del Guercio, R. W. Chesnut, and A. Sette. 1991. Single amino acid changes in DR arid antigen define residues critical for peptide-MHC binding and T cell recognition. J. Immunol. 146:2331.
4. O'Sullivan, D., T. Arrhenius, J. Sidney, M. F. Del Guercil, M. Albertson, M. Wall, C. Oseroff, S. Southwood, S. M. Colon, F. C. A. Gaeta, and A. Sette. 1991. On the interaction of promiscuous antigenic peptides with different DR allele: identification of common structural motifs. J. Immunol. 147:2663.
5. Hill, C. M., J. D. Hayball, A. A. Allison, and J. B. Rothbard. 1991. Conformational and structural characteristics of peptides binding to HLA-DR molecules. J. Immunol. 147:189.
6. Sette, A., J. Sidney, C. Oseroff, M. F. Del Guercio, S. Southwood, T. Arrhenius, M. F. Pwell, S. M. Colon, F. C. A. Gaeta, and H. M. Grey. 1993. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol. 151:3163.
7. Matsushita, S., K. Takahashi, M. Motoki, K. Komoriya, S. Ikagawa, and Y. Nishimura. 1994. Allele specificity of structural requirement for peptides bound to HLA-DRB 1*0405 and -DRB 1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J. Exp. Med. 180:873.
8. Hammer, J., E. Bono, F. Gallazzi, C. Belunis, Z. Nagy, and F. Sinigaglia. 1994. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J. Exp. Med. 180:2353.
9. Hammer, J., F. Gallazzi, E. Bono, R. W. Karr, J. Guenot, P. Valsasnini, Z. A. Nagy, and F. Sinigaglia. 1995. Peplide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181:1847.
10. Hammer, J., B. Takacs, and F. Sinigaglia. 1992. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J. Exp. Med. 176:1007.
11. Hammer, J., P. Valsasnini, K. Tolba, D. Bolin, J. Higelin, B. Takacs, and F. Sinigaglia. 1993. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74:197.
12. Rothbard, J. B., R. Busch, V. Bal, J. Trowsdale, R. I. Lechler, and J. R. Lamb. 1989. Reversal of HLA restriction by a point mutation in an antigenic peptide. Int. Immunol. 1:487.
13. Rothbard, J. B., R. Busch, K. Howtand, V. Bal, C. Fenton, W. R. Taylor, and J. R. Lamb. 1989. Structural analysis of a peptide-HLA class II complex: identification of critical interactions for its formation and recognition by T cell receptor. Int. Immunol. 1:479.
14. O'Sullivan, D., J. Sidney, M. F. Del Guercio, S. M. Colon, and A. Sette. 1991. Truncation analysis of several DR binding epitopes. J. Immunol. 146:1240.
15. Geluk, A., K. E. Van Meijgaarden, A. A. Janson, J. W. Drijfhout, R. H. Meloen, R. R. De Vries, and T. H. Ottenhoff. 1992. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR-binding motif and enables the design of allele-specific competitor peptides. J. Immunol. 149:2864.
16. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
17. Stern, L. J., J. H. Brown, T. S. Jardetzy, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
18. De Magistris, M. T., J. Alexander, M. Coggeshall, A. Altman, F. C. Gaeta, H. M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625.
19. Racioppi, L., F. Ronchese, L. A. Matis, and R. N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1047.
20. Alexander, J., K. Snoke, J. Ruppert, J. Sidner, M. Wall, S. Southwood, C. Oseroff, T. Arrhenius, F. C. A. Gatea, S. M. Colon, H. M. Grey, and A. Sette. 1993. Functional consequences of engagement of the T cell receptor by low affinity ligands. J. Immunol. 150:1.
21. Sloan-Lancaster, J., B, D. Evavold, and P. M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156.
22. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1994. Th2 cell clonal anergy as a consequence of partial activation. J. Exp. Med. 180:1195.
23. Evavold, B. D., and P. M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308.
24. Soloway, P., S. Fish, H. Passmore, M. Gefter, R. Coffee, and T. Manser. 1991. Regulation of the immune response to peplide antigens: differential induction of immediate-type hypersensitivity and T cell proliferation due to changes in either peptide structure or major histocompatibility complex haplotype. J. Exp. Med. 174:847.
25. Windhagen, A., C. Scholz, P. Hollsberg, H. Fukaura, A. Sette, and D. A. Hafler. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2:373.
26. Ikagawa, S., S. Matsushita, Y. Z. Chen, T. Ishikawa, and Y. Nishimura. 1996. Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j l)-derived peptide induced alterations in human T cell responses and T cell receptor antagonism. J. Allergy Clin. Immunol. 97:53.
27. Robbins, J. C., J. G. Spanier, S. J. Jones, W. J. Simpson, and P. P. Cleary. 1987. Streptococcus pyogenes type 12 M protein gene regulation by upstream sequences. J. Bacteriol. 169:5633.
28. + T cells specific to streptococcal antigen present in low but not in high responders. J. Immunol. 146:2560.
29. Gregersen, P. K., S. M. Goyert, Q. L. Song, and J. Silver. 1987. Microheterogeneity of HLA-DR4 haplotypes: DNA sequence analysis of LD"KT2" and LD-"TAS" haplotypes. Hum. Immunol. 19:287.
30. Inoko, H., J. G. Bodmer, J. M. Heyes, S. Drover, J. Trowsdale, and W. H. Marshall. 1992. Joint report on the transfectant/monoclonal antibody component. In HLA 1991, Vol. 1. K. Tsuji, M. Aizawa, and T. Sasazuki, eds. Oxford Science Publications, Oxford, p. 919.
31. Hirayama, K., Y. Nishimura, K. Tsukamoto, and T. Sasazuki. 1986. Functional arid molecular analysis of three distinct HLA-DR4 β-chains responsible for the MLR between HLA-Dw4, Dw 15, and DKT2. J. Immunol. 137:924.
32. Kasahara, M., T. Takenouchi, K. Ogasawara, H. Ikeda, T. Okuyama, N. Ishikawa, J. Moriuchi, A. Wakisawa, I. Kikuchi, W. Aizawa, T. Kaneko, N. Kashiwagi, Y. Nishimura, and T. Sasazuki. 1983. Serologic dissection of HLA-D specificities by the use of monoclonal antibodies. Immunogenetics 17: 485.
33. Bodmer, J. G., S. G. E. Marsh, E. D. Albert, W. F. Bodmer, B. Dupont, H. A. Erlich, B. Mach, W. R. Mayr, P. Parham, T. Sasazuki, G. M. T. Schreuder, J. L. Strominger, A. Svejgaard, and P.I. Terasaki. 1994. Nomenclature for factors of the HLA system. Hum. Immunol. 41:1.
34. Oiso, M., T, Nishi, T. Ishikawa, Y. Nishimura, and S. Matsushita. 1996. Differential binding of peptides substituted at putative C-terminal anchor residues to HLA-DQ8 and DQ9 differing only at β57. Hum. Immunol. In press.
35. Boehncke, W.-H., T. Takeshita, C. D. Pendleton, R. A. Houghten, S. Sadegh-Nasseri, L. Racioppi, J. A. Berzofsky, and R. N. Germain. 1993. The importance of dominant negative effects on amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. J. Immunol. 150:331.
36. Valitutti, S., S. Muller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148.
37. Evavold, B. D., J. Sloan-Lancaster. and P. M. Allen. 1993. Ticking the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 14:602.
38. Sloan-Lancaster, J., A. S. Saw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signaling: altered phospho-ζ and lack of Zap70 recruitment in APL-induced T cell anergy. Cell 79:913.
39. Madrenas, J., R. L. Wange, J. L. Wang, N. Isakov. L. E. Samelson, and R. N. Germain. 1995. ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267:515.
40. Wucherpfennig, K. W., and J. L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695.